These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8520850)

  • 21. Atherosclerosis in aged mice over-expressing the reverse cholesterol transport genes.
    Berti JA; de Faria EC; Oliveira HC
    Braz J Med Biol Res; 2005 Mar; 38(3):391-8. PubMed ID: 15761619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
    Quaschning T; Krane V; Metzger T; Wanner C
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remodelling of high density lipoproteins by plasma factors.
    Rye KA; Clay MA; Barter PJ
    Atherosclerosis; 1999 Aug; 145(2):227-38. PubMed ID: 10488948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis.
    Santamarina-Fojo S; Lambert G; Hoeg JM; Brewer HB
    Curr Opin Lipidol; 2000 Jun; 11(3):267-75. PubMed ID: 10882342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologic role and clinical significance of reverse cholesterol transport.
    Bleicher JM; Lacko AG
    J Am Osteopath Assoc; 1992 May; 92(5):625-32. PubMed ID: 1601697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cholesterol ester transfer protein (CETP)].
    Nakaya N
    Nihon Rinsho; 1994 Dec; 52(12):3164-9. PubMed ID: 7853706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.
    Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N
    Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse cholesterol transport: physiology and pharmacology.
    Franceschini G; Maderna P; Sirtori CR
    Atherosclerosis; 1991 Jun; 88(2-3):99-107. PubMed ID: 1892492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins.
    Lie J; de Crom R; Jauhiainen M; van Gent T; van Haperen R; Scheek L; Jansen H; Ehnholm C; van Tol A
    Biochem J; 2001 Dec; 360(Pt 2):379-85. PubMed ID: 11716766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The origin and metabolism of a nascent pre-β high density lipoprotein involved in cellular cholesterol efflux.
    Wróblewska M
    Acta Biochim Pol; 2011; 58(3):275-85. PubMed ID: 21750785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid metabolism.
    Goldberg I
    Curr Opin Lipidol; 1996 Dec; 7(6):U184-92. PubMed ID: 9117132
    [No Abstract]   [Full Text] [Related]  

  • 32. Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels.
    Brites FD; Bonavita CD; De Geitere C; Cloës M; Delfly B; Yael MJ; Fruchart J; Wikinski RW; Castro GR
    Atherosclerosis; 2000 Sep; 152(1):181-92. PubMed ID: 10996354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory assessment of HDL heterogeneity and function.
    Movva R; Rader DJ
    Clin Chem; 2008 May; 54(5):788-800. PubMed ID: 18375481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
    Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
    Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic interventions targeted at the augmentation of reverse cholesterol transport.
    Toth PP; Davidson MH
    Curr Opin Cardiol; 2004 Jul; 19(4):374-9. PubMed ID: 15218399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A-I-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk.
    Fruchart JC; De Geteire C; Delfly B; Castro GR
    Atherosclerosis; 1994 Oct; 110 Suppl():S35-9. PubMed ID: 7857382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detailed molecular model of apolipoprotein A-I on the surface of high-density lipoproteins and its functional implications.
    Segrest JP; Harvey SC; Zannis V
    Trends Cardiovasc Med; 2000 Aug; 10(6):246-52. PubMed ID: 11282302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice.
    Tailleux A; Bouly M; Luc G; Castro G; Caillaud JM; Hennuyer N; Poulain P; Fruchart JC; Duverger N; Fiévet C
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2453-8. PubMed ID: 11073852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.